June 2026 in “Skin Appendage Disorders” This source reviews the use of topical tretinoin with minoxidil for androgenetic alopecia, indicating that while combined use may convert some minoxidil nonresponders to responders, clinical evidence is limited and increased absorption may lead to irritation concerns.
May 2026 in “Skin Appendage Disorders” This study found that combining platelet-rich plasma with systemic therapies for androgenetic alopecia may result in greater improvements in hair density and width than using PRP alone, though the differences were not statistically significant.
April 2026 in “Journal of the American Academy of Dermatology” Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.
April 2026 in “International Journal of Dermatology” This review explores the potential links between PRP treatments for hair loss and scalp skin cancer risk, finding current evidence supports PRP's safety but emphasizes the need for further studies and routine monitoring.
April 2026 in “Journal of the American Academy of Dermatology” September 2025 in “Journal of the American Academy of Dermatology” This study explores patients' perceptions of hair loss treatments, specifically oral minoxidil, topical minoxidil, and oral finasteride, building on existing clinical research.
December 2002 in “Operative Techniques in Otolaryngology-Head and Neck Surgery” This article reviews special techniques for reconstructing the appearance of patients with scalp injuries, highlighting the versatility of scalp expansion, advancement flaps, and follicular unit hair transplantation, and reports no new clinical results.
January 2026 in “International Journal of Medicine in Developing Countries” This study found significant gaps in knowledge, treatment awareness, and healthcare-seeking practices related to alopecia among the general population in Jazan, Saudi Arabia.
25 citations
,
December 2021 in “Stem Cell Research & Therapy” This review discusses the potential of mesenchymal stem/stromal cells and their exosomes in promoting wound healing and skin regeneration, but reports no new experimental results.
August 2026 in “International Journal of Dermatology” This article discusses the availability of data from TriNetX for research purposes and reports no new findings.
694 citations
,
April 2000 in “Nature genetics” This study found that Msx2-deficient mice exhibit skull and bone formation defects similar to those seen in human MSX2-related conditions, highlighting the gene's importance in skeletal and organ development.
184 citations
,
September 2006 in “PLoS Genetics” This study found that loss of Apc due to K14-cre-mediated gene recombination in mice led to aberrant growth in ectodermally derived squamous epithelia, implicating its critical role in specifying epithelial cell fates during embryonic development.
158 citations
,
December 2002 in “Development” In this study, Msx2-deficient mice showed progressive hair loss due to shortened anagen phase and prolonged catagen and telogen phases, resulting in cyclic alopecia with structurally abnormal hair shafts.
55 citations
,
April 2008 in “Clinical Genetics” This report identifies a novel mutation in the ST14 gene in a female with autosomal recessive ichthyosis with hypotrichosis, highlighting similar features to previously reported cases.
47 citations
,
September 2022 in “European Heart Journal” This consensus document reviews current knowledge on sex differences in essential hypertension and identifies areas needing further research to improve sex-specific prevention and management strategies.
18 citations
,
June 2018 in “Journal of Dental Research” This study found that during amelogenesis in Msx2 null mice, a dysfunctional enamel organ developed due to abnormal epithelial transformation and lacked proper enamel formation.
1 citations
,
January 2024 in “Arab Board Medical Journal” This study found that tofacitinib was an effective and well-tolerated treatment for alopecia areata, with significant to moderate hair regrowth in 78% of patients observed.
August 2026 in “JAAD Case Reports” July 2026 in “Journal of Investigative Dermatology” July 2026 in “Journal of Investigative Dermatology” July 2026 in “Skin Appendage Disorders” This study found that public sentiment towards androgenetic alopecia treatments is generally negative, with over-the-counter therapies perceived more positively than prescription options despite weaker clinical evidence.
July 2026 in “Journal of the American Academy of Dermatology” The occipital scalp is affected in advanced hair loss, so it shouldn't be used as a control.
June 2026 in “Skin Appendage Disorders” This review discusses diffuse unpatterned alopecia (DUPA) as an understudied variant of androgenetic alopecia, summarizing its presentation and management while calling for further research to better understand its distinct characteristics.
June 2026 in “JAAD Case Reports” March 2026 in “Journal of Investigative Dermatology”
February 2026 in “American Journal of Clinical Dermatology” Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.
August 2025 in “Skin Appendage Disorders” This study reported that the combination of tacrolimus, clobetasol, and minoxidil improved hair measurements and stabilized inflammation in primary cicatricial alopecia patients, with most tolerating the treatment well.
December 2002 in “Operative Techniques in Otolaryngology-head and Neck Surgery” This article reviews techniques for restoring appearance following scalp injuries and highlights the versatility of scalp expansion, advancement flaps, and follicular unit hair transplantation, but it provides no new clinical results.
10 citations
,
May 2014 in “Facial Plastic Surgery” This study reported that partial longitudinal follicular unit transplantation improved eyebrow appearance and patient satisfaction without visible scarring, making it a reliable method for eyebrow restoration.
237 citations
,
January 2010 in “The Journal of Sexual Medicine” The authors updated recommendations on diagnosing and treating women's sexual dysfunctions, emphasizing a comprehensive assessment approach, while noting the need for further multidisciplinary research.